This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES Asia: Oligonucleotide & Peptide Therapeutics
24-26 Feb, 2026
Grand Nikko Tokyo DaibaTokyo

Sartorius Stedim

Profile

We provide the tools, technologies, and services that enable pharmaceutical and biopharmaceutical companies, as well as academic researchers, to bring new therapies and medicines to market faster and more efficiently.

We offer a broad portfolio of solutions that support the entire life science process, from discovery in the laboratory to clinical and commercial production. Our innovative range of laboratory equipment and consumables, process technologies, and single-use systems enhances experimental accuracy and safety while increasing production speed and scalability.

Founded in 1870, Sartorius has contributed to scientific progress and the improvement of human health for more than 150 years. Guided by our shared mission, “better health for more people,” we work hand in hand with our customers to simplify and accelerate research and manufacturing challenges. Sartorius’ advanced technologies and dedicated support help accelerate drug discovery and development, ultimately shaping a better future for patients.

We're bringing you

  • Enhancing GLP-1 Manufacturing: Addressing TFF Challenges

    11:00am